Anagram
Anagram is a healthcare technology company based in San Francisco, California. It specializes in providing insurance billing and revenue cycle management software specifically for eye care practices. The company offers an all-in-one billing platform that automates various processes, including vision insurance verification, claims processing, billing, lab ordering, and rebate management. Anagram's solutions are designed to assist optometrists, ophthalmologists, and opticians in managing both in-network and out-of-network vision plans. Key features of their platform include eligibility and bene
Investing activity
Anagram appears in 3 AI deals tracked by the AI Lounge deals desk, and led 2 of them. The rounds are mostly Seed, with a median round size of $5M and the largest at $10M. The most recent are VeryAI (Seed, $10M, Aug 2026), t54 Labs (Seed, $5M, Aug 2026) and t54 Labs (Seed, $5M, Feb 2026).
Anagram most often invests alongside PL Capital, Franklin Templeton, Virtuals Ventures and Ripple, and the companies it backs on AI Lounge are mostly in AI.
Deals
Frequently asked questions about Anagram
What AI companies has Anagram invested in?
Anagram's AI investments include VeryAI and t54 Labs. The 3 rounds on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Anagram based?
Anagram is based in San Jose, San Jose, Costa Rica.
What stage does Anagram invest at?
In the rounds tracked on AI Lounge, Anagram has invested at Seed, with a median round of $5M. Anagram led 2 of those rounds.
Who does Anagram co-invest with?
Anagram's most frequent co-investors on AI Lounge are PL Capital (2 deals), Franklin Templeton (2 deals), Virtuals Ventures (2 deals), Ripple (2 deals) and Polychain Capital (1 deal).
How can founders reach Anagram?
Founders on AI Lounge can see Anagram's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Anagram to their Investor Pipeline to track the conversation.